N790
Research N790 on Bullrun: market cap EUR 2.76M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerN790
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 2.76M
- Financial periodQ1 2026
- RevenueCAD 0
- Net income-CAD 2.16M
- Free cash flow-CAD 1.61M
Valuation Snapshot
latest market cap is EUR 2.76M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 0 | -CAD 540.83K | CAD 475.70K | n/a | n/a | CAD 1.48M | CAD 35.00K | CAD 1.49M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | EUR 2.76M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About N790
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
Related stock research
Other Healthcare stocks
Entheon Biomedical Corp. (1XU)
NANOSPHERE HEA.SCIENCES (2CG)
MedMira Inc (47M)
BRAXIA SCIENTIFIC CORP. (4960)
WAVERLEY PHARMA INC. (5GZ)
BioVaxys Technology Corp. (5LB0)
GLOW LIFETECH CORP. (9DO)
NERVGEN PHARMA CORP. (9UA)
AbCellera Biologics Inc (ABCL)
Appili Therapeutics Inc (APLI)
Arch Biopartners Inc (ARCH)
Aurinia Pharmaceuticals Inc (AUPH)
Frequently asked questions
What is N790's market cap?
N790's market capitalization is EUR 2.76M.
What does N790 do?
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.